Professor Luis Miguel Ortega Mora

Further involvements

• Mo, 27/05/2024

  • Poster presentation
  • P047

  Treatment with BKI-1748 after Toxoplasma gondii systemic dissemination in experimentally infected sheep significantly improves clinical outcome and prevents congenital infection

   Metabolism, Biochemistry & Drug Development
• Mo, 27/05/2024

  • Poster presentation
  • P049

  In vitro models using target ovine cell lines to evaluate the Toxoplasma gondii phenotype

   Host-Parasite Interaction & Signalling
• Mo, 27/05/2024

  • Poster presentation
  • P055

  Genotyping of European Toxoplasma gondii strains by a new high-resolution next-generation sequencing-based method

   Epidemiology, Public Health and Clinical Aspects of Toxoplasmosis
• Mo, 27/05/2024

  • Poster presentation
  • P063

  Serological and molecular survey of Toxoplasma gondii infection in wild carnivores of the Iberian Peninsula

   Epidemiology, Public Health and Clinical Aspects of Toxoplasmosis
• Tu, 28/05/2024

  14:45 – 15:00 12 Min. 3 Min.

  • Oral presentation
  • T49

  Usefulness of serotyping tools in Toxoplasma gondii infections in sheep and pigs

   Epidemiology, Public Health and Clinical Aspects of Toxoplasmosis
• Tu, 28/05/2024

  • Poster presentation
  • P036

  Activity and efficacy of the bumped kinase inhibitor BKI-1708 in vitro and in non-pregnant and pregnant toxoplasmosis and neosporosis mouse models

   Metabolism, Biochemistry & Drug Development
• Tu, 28/05/2024

  • Poster presentation
  • P080

  Short-term in vitro culture adaptation of Toxoplasma gondii archetypal II and III field isolates induces relevant changes in the transcriptomic profile

   Stage Conversion & Developmental Biology